ArticleJAMA oncology2020

Characterization of the Cancer Spectrum in Men With Germline BRCA1 and BRCA2 Pathogenic Variants: Results From the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA).

Valentina Silvestri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.